Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Yang X, Wang K, Lang J, Guo D, Gao H, Qiu Y, et al
Participants receiving the highest dose (12 mg weekly) achieved a mean body weight reduction of approximately 24% from baseline at 48 weeks a figure that, whilst encouraging, should be interpreted with caution as cross-trial comparisons with approved agents are not methodologically robust in the absence of head-to-head data
demonstrated improved cognitive performance compared to those with lower intake rates [11]
Zepbound, Wegovy, and Saxenda are also approved for people who are overweight and have at least one weight-related condition (high blood pressure, high cholesterol, etc.) that could be improved with weight loss
Food and Drug Administration (FDA) for weight loss or type 2 diabetes, and it is not available for prescription or compounding use in the United States
Most clinical weight loss data comes from the standard 2.5 mg starting dose and above
US$ 27.31
US$ 28.54
US$ 25.04
US$ 21.96
US$ 25.35
